Posts by Anderson

National Advertising Division Refers Advertising Claims by Guardian Technologies for its GermGuardian and PureGuardian Air Purifiers to FTC After Advertiser Refuses to Comply with Recommendations

NAD has referred advertising claims made by Guardian Technologies, LLC to the Federal Trade Commission for possible enforcement action after the company stated it would not comply with NAD’s recommendations to discontinue certain HEPA performance claims for its GermGuardian and PureGuardian air purifiers and replacement filters. This challenge was initiated by Dyson, Inc., maker of competing air purification products.

Read More

NAD Recommends Reckitt Benckiser Discontinue Certain Challenged Claims for Air Wick Scented Oil

NAD recommended that Reckitt Benckiser LLC discontinue certain challenged claims for Air Wick Scented Oil, following a challenge by The Procter & Gamble Company, maker of Febreze Air Fresheners.

Read More

NAD Recommends Skyline Discontinue Certain Performance Claims for its Guard Dog Pepper Spray Following Challenge by SABRE

NAD has recommended that Skyline USA, Inc. discontinue certain performance claims for its Guard Dog pepper spray relating to its range, effectiveness, capacity, and ability to ensure assailant identification days after use. The claims for this personal defense device sold on the consumer market, were challenged by SABRE, a subsidiary of Security Equipment Corporation.

Read More

NAD Recommends Alcon Vision Discontinue Certain Challenged Claims in Professional Advertising for Intraocular Lenses, Finds Certain Claims Supported

NAD recommended that Alcon Vision, LLC discontinue certain challenged claims in professional advertising for its AcrySof IQ ReSTOR +2.5 D and +3.0 D Multifocal Intraocular Lenses, following a challenge by Johnson & Johnson Surgical Vision, Inc. (“JJSV”), maker of competing TECNIS Symfony intraocular lenses. Intraocular lenses (“IOLs”) are implantable medical devices that surgeons use to replace patients’ natural lenses after they are removed during cataract surgery.

Read More

NAD Recommends Molekule Discontinue Pollution Elimination, Asthma and Allergy Symptom Relief Claims for its Molekule Home One Air Purifier; Advertiser to Appeal Certain Findings

NAD has recommended that Molekule Inc. discontinue its pollution, bioaerosol and VOC elimination/destruction claims (both quantified and otherwise), performance claims concerning its MH1 Air Purifier (MH1), its comparative superiority claims versus air purifiers that contain HEPA filters, and its allergy and asthma symptom relief claims, following a challenge by Dyson, Inc., maker of competing air purifiers. The advertiser has said it will appeal certain NAD findings and recommendations to the NARB but will comply with other recommendations.

Read More